MustGrow Biologics Corp.
MGROF
$0.41
$0.013.56%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -72.18% | -21.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -72.18% | -21.84% | |||
| Cost of Revenue | -71.21% | -24.03% | |||
| Gross Profit | -77.82% | -6.07% | |||
| SG&A Expenses | 85.27% | -21.58% | |||
| Depreciation & Amortization | 1.04% | 28.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.19% | -23.32% | |||
| Operating Income | -162.55% | 27.79% | |||
| Income Before Tax | -124.13% | 31.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -124.13% | 31.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -124.13% | 31.14% | |||
| EBIT | -162.55% | 27.79% | |||
| EBITDA | -164.35% | 28.03% | |||
| EPS Basic | -113.25% | 27.75% | |||
| Normalized Basic EPS | -114.89% | 28.24% | |||
| EPS Diluted | -113.25% | 27.75% | |||
| Normalized Diluted EPS | -114.89% | 28.24% | |||
| Average Basic Shares Outstanding | 4.95% | -4.66% | |||
| Average Diluted Shares Outstanding | 4.95% | -4.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||